Back
Cidara Therapeutics Stock Price Chart

7 Stocks to Consider Immediately (must-see chart)
See the green days for 7 major stocks right here, free of charge
Buy
77
CDTX
Cidara Therapeutics
Last Price:
$52.76
Seasonality Move:
-8.55%
7 Day Trial
ALL ACCESS PASS
$
7

This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CDTX is experiencing buying pressure, which is a positive indicator for future bullish movement.
Cidara Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 50.39 | Buy |
20-day SMA: | 42.46 | Buy |
50-day SMA: | 30.72 | Buy |
200-day SMA: | 21.84 | Buy |
8-day EMA: | 50.49 | Buy |
20-day EMA: | 44.06 | Buy |
50-day EMA: | 34.72 | Buy |
200-day EMA: | 23.97 | Buy |
Cidara Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 6.91 | Buy |
Relative Strength Index (14 RSI): | 81.84 | Buy |
Chaikin Money Flow: | 1154906 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (26.31 - 51.77) | Buy |
Bollinger Bands (100): | (15.88 - 36.04) | Buy |
Cidara Therapeutics Technical Analysis
Jun 30 | Jul 1 | Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
30 | 01 | 02 | 03 | 07 | 08 | 09 | 10 | 11 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Cidara Therapeutics Stock
Is Cidara Therapeutics Stock a Buy?
-
Cidara Therapeutics share price is 55.32 while CDTX 8-day simple moving average is 50.39, which is a Buy signal.
-
The stock price of CDTX is 55.32 while Cidara Therapeutics 20-day SMA is 42.46, which makes it a Buy.
-
Cidara Therapeutics 50-day simple moving average is 30.72 while CDTX share price is 55.32, making it a Buy technically.
-
CDTX stock price is 55.32 and Cidara Therapeutics 200-day simple moving average is 21.84, creating a Buy signal.
CDTX Technical Analysis vs Fundamental Analysis
Buy
77
Cidara Therapeutics (CDTX)
is a Buy
Is Cidara Therapeutics a Buy or a Sell?
-
Cidara Therapeutics stock is rated a BuyThe current Cidara Therapeutics [CDTX] share price is $55.32. The Score for CDTX is 77, which is 54% above its historic median score of 50, and infers lower risk than normal.
Cidara Therapeutics Stock Info
Market Cap:
1.2B
Price in USD:
55.32
Share Volume:
1.3M
Cidara Therapeutics 52-Week Range
52-Week High:
56.83
52-Week Low:
10.14
Buy
77
Cidara Therapeutics (CDTX)
is a Buy
Cidara Therapeutics Share Price Forecast
-
What is the Cidara Therapeutics stock price today?The Cidara Therapeutics stock price is 55.32 USD today.
-
Will CDTX stock go up or go down?Cidara Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Cidara Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Cidara Therapeutics is not overvalued.
Is Cidara Therapeutics Stock a Buy?
-
Cidara Therapeutics share price is 55.32 while CDTX 8-day exponential moving average is 50.49, which is a Buy signal.
-
The stock price of CDTX is 55.32 while Cidara Therapeutics 20-day EMA is 44.06, which makes it a Buy.
-
Cidara Therapeutics 50-day exponential moving average is 34.72 while CDTX share price is 55.32, making it a Buy technically.
-
CDTX stock price is 55.32 and Cidara Therapeutics 200-day simple moving average is 23.97, creating a Buy signal.
Fundamental Analysis of Cidara Therapeutics
Is Cidara Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $3.78 per share, a decrease next quarter of $0.00 per share, an increase this year of $15.76 per share, and a decrease next year of $0.53 per share.
Technical Analysis of Cidara Therapeutics
Should I short Cidara Therapeutics stock?
-
CDTX Moving Average Covergence Divergence (MACD) indicator is 6.91, suggesting Cidara Therapeutics is a Buy
-
Cidara Therapeutics Relative Strength Index (RSI) is 81.84, which suggest Cidara Therapeutics is overbought
-
The Bollinger Bands (25) for Cidara Therapeutics is (26.31 - 51.77), which suggest Cidara Therapeutics is a Buy
-
The Bollinger Bands (100) for Cidara Therapeutics is (15.88 - 36.04), which suggest Cidara Therapeutics is a Buy
* Cidara Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.